Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare
Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to drugmakers.
Overview
Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to drugmakers.
Source
Originally published at www.cnbc.com.
Related Articles
- Down About 16% and Trading at 16 Times Earnings, Is Domino's a Long-Term Buy Today?
- Vanguard vs iShares: Which Short Term Bond ETF Offers Investors Better Value?
- Meet the Artificial Intelligence (AI) Inference Stock That Could Deliver the Biggest Gains Over the Next 3 Years (Hint: It's not Nvidia or Broadcom)
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.